Filed: 5/15/2026ACC: 0001958125-26-000003
📋 What this filing means
CATALIO CAPITAL MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 41 equity positions with a total reported market value of $478.70M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
41
Positions
$478.70M
Total AUM (reported)
22.42M
Total Shares
Allocation by class
COM$362.52M75.7%
SPONSORED ADR$29.53M6.2%
COM SHS$20.31M4.2%
COM NEW$20.12M4.2%
SPONSORED ADS$17.56M3.7%
COMMON STOCK$10.96M2.3%
SHS$8.03M1.7%
Portfolio Concentration
Top 3$108.63M22.7%
4–10$152.05M31.8%
11–25$174.55M36.5%
Rest$43.47M9.1%
Top 3 weight
22.7%
Top 10 weight
54.5%
Voting Authority Distribution
Total shares with voting rights: 22.42M
Sole
Full voting authority
22.42M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole41
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings41
Rows:
DIANTHUS THERAPEUTICS INC
SOLEShares560.31K
TypeSH
Market value$47.02M
9.82%
Sole
560.31K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares432.01K
TypeSH
Market value$32.08M
6.70%
Sole
432.01K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares129.11K
TypeSH
Market value$29.53M
6.17%
Sole
129.11K
Shared
0.00
None
0.00
BRISTOL-MYERS SQUIBB CO
SOLEShares420.73K
TypeSH
Market value$25.52M
5.33%
Sole
420.73K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares1.04M
TypeSH
Market value$24.38M
5.09%
Sole
1.04M
Shared
0.00
None
0.00
GILEAD SCIENCES INC
SOLEShares163.91K
TypeSH
Market value$22.84M
4.77%
Sole
163.91K
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares409.03K
TypeSH
Market value$21.56M
4.50%
Sole
409.03K
Shared
0.00
None
0.00
DEFINIUM THERAPEUTICS INC
SOLEShares1.04M
TypeSH
Market value$19.62M
4.10%
Sole
1.04M
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares577.81K
TypeSH
Market value$19.35M
4.04%
Sole
577.81K
Shared
0.00
None
0.00
BOSTON SCIENTIFIC CORP
SOLEShares299.32K
TypeSH
Market value$18.78M
3.92%
Sole
299.32K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares850.80K
TypeSH
Market value$17.82M
3.72%
Sole
850.80K
Shared
0.00
None
0.00
INCYTE CORP
SOLEShares182.10K
TypeSH
Market value$17.14M
3.58%
Sole
182.10K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares215.50K
TypeSH
Market value$14.20M
2.97%
Sole
215.50K
Shared
0.00
None
0.00
NATERA INC
SOLEShares70.91K
TypeSH
Market value$14.18M
2.96%
Sole
70.91K
Shared
0.00
None
0.00
CORVUS PHARMACEUTICALS INC
SOLEShares891.93K
TypeSH
Market value$13.05M
2.73%
Sole
891.93K
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares255.38K
TypeSH
Market value$12.31M
2.57%
Sole
255.38K
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares439.04K
TypeSH
Market value$11.89M
2.48%
Sole
439.04K
Shared
0.00
None
0.00
EDWARDS LIFESCIENCES CORP
SOLEShares144.61K
TypeSH
Market value$11.58M
2.42%
Sole
144.61K
Shared
0.00
None
0.00
VERADERMICS INC
SOLEShares173.58K
TypeSH
Market value$10.96M
2.29%
Sole
173.58K
Shared
0.00
None
0.00
ADAPTIVE BIOTECHNOLOGIES COR
SOLEShares722.78K
TypeSH
Market value$10.03M
2.10%
Sole
722.78K
Shared
0.00
None
0.00
HEARTFLOW INC
SOLEShares403.59K
TypeSH
Market value$9.82M
2.05%
Sole
403.59K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares426.55K
TypeSH
Market value$8.59M
1.79%
Sole
426.55K
Shared
0.00
None
0.00
UNIQURE NV
SOLEShares491.12K
TypeSH
Market value$8.03M
1.68%
Sole
491.12K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares122.98K
TypeSH
Market value$7.86M
1.64%
Sole
122.98K
Shared
0.00
None
0.00
SEPTERNA INC
SOLEShares294.36K
TypeSH
Market value$7.07M
1.48%
Sole
294.36K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DIANTHUS THERAPEUTICS INCSOLE | COM | 560.31K | SH | $47.02M 9.82% | 560.31K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 432.01K | SH | $32.08M 6.70% | 432.01K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 129.11K | SH | $29.53M 6.17% | 129.11K | 0.00 | 0.00 |
BRISTOL-MYERS SQUIBB COSOLE | COM | 420.73K | SH | $25.52M 5.33% | 420.73K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 1.04M | SH | $24.38M 5.09% | 1.04M | 0.00 | 0.00 |
GILEAD SCIENCES INCSOLE | COM | 163.91K | SH | $22.84M 4.77% | 163.91K | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 409.03K | SH | $21.56M 4.50% | 409.03K | 0.00 | 0.00 |
DEFINIUM THERAPEUTICS INCSOLE | COM SHS | 1.04M | SH | $19.62M 4.10% | 1.04M | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 577.81K | SH | $19.35M 4.04% | 577.81K | 0.00 | 0.00 |
BOSTON SCIENTIFIC CORPSOLE | COM | 299.32K | SH | $18.78M 3.92% | 299.32K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 850.80K | SH | $17.82M 3.72% | 850.80K | 0.00 | 0.00 |
INCYTE CORPSOLE | COM | 182.10K | SH | $17.14M 3.58% | 182.10K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 215.50K | SH | $14.20M 2.97% | 215.50K | 0.00 | 0.00 |
NATERA INCSOLE | COM | 70.91K | SH | $14.18M 2.96% | 70.91K | 0.00 | 0.00 |
CORVUS PHARMACEUTICALS INCSOLE | COM | 891.93K | SH | $13.05M 2.73% | 891.93K | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 255.38K | SH | $12.31M 2.57% | 255.38K | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 439.04K | SH | $11.89M 2.48% | 439.04K | 0.00 | 0.00 |
EDWARDS LIFESCIENCES CORPSOLE | COM | 144.61K | SH | $11.58M 2.42% | 144.61K | 0.00 | 0.00 |
VERADERMICS INCSOLE | COMMON STOCK | 173.58K | SH | $10.96M 2.29% | 173.58K | 0.00 | 0.00 |
ADAPTIVE BIOTECHNOLOGIES CORSOLE | COM | 722.78K | SH | $10.03M 2.10% | 722.78K | 0.00 | 0.00 |
HEARTFLOW INCSOLE | COM | 403.59K | SH | $9.82M 2.05% | 403.59K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 426.55K | SH | $8.59M 1.79% | 426.55K | 0.00 | 0.00 |
UNIQURE NVSOLE | SHS | 491.12K | SH | $8.03M 1.68% | 491.12K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 122.98K | SH | $7.86M 1.64% | 122.98K | 0.00 | 0.00 |
SEPTERNA INCSOLE | COM | 294.36K | SH | $7.07M 1.48% | 294.36K | 0.00 | 0.00 |
Page 1 of 2